"State laws matter." -- Patricia Logan-Greene, PhD, of the State University of New York at Buffalo, on an analysis that found ...

Called enpatoran, the agent targets the Toll-like receptor (TLR) species 7 and 8. Some 50%-60% of patients with systemic ...

HHS Secretary Robert F. Kennedy Jr. said in April that he plans to tell medical schools to teach nutrition or risk losing ...

BARCELONA -- The oral drug deucravacitinib (Sotyktu) passed what is probably its final test as a treatment for psoriatic ...

Cuts to Medicaid and other federal health programs proposed in President Donald Trump's budget plan would rapidly push more ...

Wade, Medicaid expansion, marijuana decriminalization, and the rights of same-sex couples prior to Obergefell v. Hodges. Now, ...

Note that some links may require registration or subscription. The United Kingdom's Food Standards Agency says that certain ...

At their annual meeting, American Medical Association (AMA) delegates passed a resolution calling for a Senate investigation ...

Subsequent studies by other investigators confirmed those early results, ultimately leading to the FDA approval of ...

SEATTLE -- Psychological evaluation before implantation of a hypoglossal nerve stimulation (HNS) device to treat obstructive ...

Sustained remission at 10 years was more common as well among the patients starting anti-TNFs right away, Toyoda told ...

BARCELONA -- A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory ...